Pompe Disease Treatment Market

Pompe disease is a rare disease, also known as acid maltase deficiency (AMD) or glycogen storage disorder (GSD).Glycogenosis II is also called "glycogenosis type 2".

Pompe Disease Treatment Market contains market size and forecasts of Pompe Disease Treatment in Global, including the following market information:

• Global Pompe Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Pompe Disease Treatment market was valued at 972.6 million in 2021 and is projected to reach US$ 1116.5 million by 2028, at a CAGR of 2.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Infantile-Onset Pompe Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pompe Disease Treatment include Amicus Therapeutics, Audentes Therapeutics, Sanofi Genzyme, EpiVax, Oxyrane, Sangamo BioSciences and Valerion Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Pompe Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pompe Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pompe Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Infantile-Onset Pompe Disease
• Adult-Onset Pompe Disease

Global Pompe Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pompe Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Center
• Other

Global Pompe Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pompe Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Pompe Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Pompe Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amicus Therapeutics
• Audentes Therapeutics
• Sanofi Genzyme
• EpiVax
• Oxyrane
• Sangamo BioSciences
• Valerion Therapeutics